Back to VP Vanguard Portfolio Management LLC
URGN2 quarters
Position history for VPVanguard Portfolio Management LLC's holdings in UroGen Pharma Ltd.
Yes. Vanguard Portfolio Management holds 456,558 shares of URGN (UroGen Pharma), worth $16.8M, as of its Q2 2026 13F filing. It increased the position by 47,001 shares (+11.5%) from Q1 2026. Vanguard Portfolio Management has held URGN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$16.8M
Current Shares
456,558
Total Value Change
+$9.4M
Total Shares Change
+47,001
Quarter-by-Quarter History
Other major holders of URGN: RTW Investments, LP, BlackRock, Inc., Menora Mivtachim Holdings Ltd.